Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway-Reference-Cited by-同舟云学术

Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kim Jeong Hun¹²³,Lee Won Suk¹²,Lee Hye Jin¹²³,Yang Hannah¹²,Lee Seung Joon¹³,Kong So Jung¹²,Je Soyeon⁴,Yang Hyun-Jin⁴,Jung Jongsun⁵,Cheon Jaekyung¹²³,Kang Beodeul¹²³,Chon Hong Jae¹²³^ORCID,Kim Chan¹²³^ORCID

Affiliation:

1. Laboratory of Translational Immuno-Oncology, Seongnam, Korea

2. Medical Oncology, Department of Internal Medicine,CHA Bundang Medical Center, Cha University, Seongnam, Korea

3. Graduate School of Department of Biomedical Science, Cha University, Seongnam, Korea

4. Medical Science Study Centre, Syntekabio Inc, Seoul, South Korea

5. Insilico Clinical Trial Research Center, Syntekabio Inc, Daejeon, South Korea

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.2005280

Reference55 articles.

1. Cancer immunotherapy using checkpoint blockade

2. The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment

3. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

4. Sequential Treatment with an Immune Checkpoint Inhibitor Followed by a Small-Molecule Targeted Agent Increases Drug-Induced Pneumonitis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Factors Contribute to the Acceptance of Artificial Intelligence on Healthcare Sector: A Systematic Review;2023 3rd International Conference on Intelligent Cybernetics Technology & Applications (ICICyTA);2023-12-13

2. Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy;ACS Central Science;2023-09-22

3. Modulation of T cells by tryptophan metabolites in the kynurenine pathway;Trends in Pharmacological Sciences;2023-07

4. Prediction of IDO1 Inhibitors by a Fingerprint‐Based Stacking Ensemble Model Named IDO1Stack;ChemMedChem;2023-06-30

5. High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma;Cancers;2022-12-03